Silver Book Fact

A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.

Lunn M, Hughes R, Wiffen P. Duloxetine for Treating Painful Neuropathy or Chronic Pain. Cochrane Database of Systematic Reviews. 2009; 4. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007115.pub2/abstract

Reference

Title
Duloxetine for Treating Painful Neuropathy or Chronic Pain
Publication
Cochrane Database of Systematic Reviews
Publication Date
2009
Authors
Lunn M, Hughes R, Wiffen P
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Opioids have been found to reduce pain intensity and improve physical functioning for patients with persistent noncancer pain. It’s important to note that a decrease in mental health functioning…  
  • The Mayo Clinic Pain Rehabilitation Center helps people with persistent pain return to an active lifestyle and has found that among patients who finish the program, nearly 84% report greater…  
  • Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.  
  • Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.  
  • Understanding the role of genetics in pain mechanisms is increasing and the potential now exists to conduct genome-wide screens in model organisms to look for pain-associated genes.